Cover Image
Market Research Report

Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2017

Published by GlobalData Product code 253072
Published Content info 282 Pages
Immediate Delivery Available
Price
Back to Top
Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2017
Published: May 31, 2017 Content info: 282 Pages
Description

GlobalData's clinical trial report, "Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2017" provides an overview of Chemotherapy Induced Nausea and Vomiting clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Nausea and Vomiting. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC4257CTIDB

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Nausea and Vomiting to Toxicology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Chemotherapy Induced Nausea and Vomiting to Toxicology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 280

  • Abbreviations 280
  • Definitions 280
  • Research Methodology 281
  • Secondary Research 281
  • About GlobalData 282
  • Contact Us 282
  • Source 282

List of Tables

List of Tables

  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
  • Proportion of Chemotherapy Induced Nausea and Vomiting to Toxicology Clinical Trials, G7 Countries (%), 2017* 15
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Chemotherapy Induced Nausea and Vomiting to Toxicology Clinical Trials, E7 Countries (%), 2017* 18
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
  • Proportion of Chemotherapy Induced Nausea and Vomiting to Toxicology Clinical Trials, G7 Countries (%), 2017* 15
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Chemotherapy Induced Nausea and Vomiting to Toxicology Clinical Trials, E7 Countries (%), 2017* 18
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Chemotherapy Induced Nausea and Vomiting Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 281
Back to Top